Free Trial

Cooper Companies (COO) Competitors

Cooper Companies logo
$72.63 -0.63 (-0.86%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$72.26 -0.38 (-0.52%)
As of 07/18/2025 07:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

COO vs. WST, ALGN, MMSI, HAE, ICUI, XRAY, QDEL, NEOG, STAA, and CERS

Should you be buying Cooper Companies stock or one of its competitors? The main competitors of Cooper Companies include West Pharmaceutical Services (WST), Align Technology (ALGN), Merit Medical Systems (MMSI), Haemonetics (HAE), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), Neogen (NEOG), STAAR Surgical (STAA), and Cerus (CERS). These companies are all part of the "health care supplies" industry.

Cooper Companies vs. Its Competitors

Cooper Companies (NASDAQ:COO) and West Pharmaceutical Services (NYSE:WST) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, risk, media sentiment, analyst recommendations and institutional ownership.

24.4% of Cooper Companies shares are owned by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are owned by institutional investors. 2.0% of Cooper Companies shares are owned by company insiders. Comparatively, 0.5% of West Pharmaceutical Services shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Cooper Companies currently has a consensus price target of $97.20, indicating a potential upside of 33.83%. West Pharmaceutical Services has a consensus price target of $320.00, indicating a potential upside of 51.72%. Given West Pharmaceutical Services' stronger consensus rating and higher probable upside, analysts clearly believe West Pharmaceutical Services is more favorable than Cooper Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cooper Companies
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.73
West Pharmaceutical Services
0 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.89

West Pharmaceutical Services has lower revenue, but higher earnings than Cooper Companies. West Pharmaceutical Services is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cooper Companies$3.99B3.64$392.30M$2.0635.26
West Pharmaceutical Services$2.89B5.24$492.70M$6.3733.11

In the previous week, Cooper Companies had 8 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 17 mentions for Cooper Companies and 9 mentions for West Pharmaceutical Services. West Pharmaceutical Services' average media sentiment score of 1.04 beat Cooper Companies' score of 0.81 indicating that West Pharmaceutical Services is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cooper Companies
9 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
3 Negative mention(s)
1 Very Negative mention(s)
Positive
West Pharmaceutical Services
6 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

West Pharmaceutical Services has a net margin of 16.13% compared to Cooper Companies' net margin of 10.39%. West Pharmaceutical Services' return on equity of 18.23% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Cooper Companies10.39% 9.60% 6.35%
West Pharmaceutical Services 16.13%18.23%13.51%

Cooper Companies has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500. Comparatively, West Pharmaceutical Services has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500.

Summary

West Pharmaceutical Services beats Cooper Companies on 12 of the 17 factors compared between the two stocks.

Get Cooper Companies News Delivered to You Automatically

Sign up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COO vs. The Competition

MetricCooper CompaniesMED/DENTAL IndustryMedical SectorNASDAQ Exchange
Market Cap$14.52B$15.39B$5.54B$9.43B
Dividend YieldN/A1.48%4.00%4.03%
P/E Ratio35.2618.0228.2619.77
Price / Sales3.642.28414.5488.61
Price / Cash12.9916.6835.8558.18
Price / Book1.793.718.115.65
Net Income$392.30M$430.42M$3.25B$257.97M
7 Day Performance-2.86%-1.89%1.63%3.74%
1 Month Performance4.55%0.58%7.62%11.95%
1 Year Performance-19.97%13.50%32.74%19.22%

Cooper Companies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COO
Cooper Companies
3.2926 of 5 stars
$72.63
-0.9%
$97.20
+33.8%
-20.0%$14.52B$3.99B35.2616,000Analyst Forecast
WST
West Pharmaceutical Services
4.7813 of 5 stars
$221.49
-0.3%
$320.00
+44.5%
-33.7%$15.91B$2.90B34.7710,600Positive News
Upcoming Earnings
ALGN
Align Technology
4.8768 of 5 stars
$193.83
-1.5%
$241.25
+24.5%
-24.2%$14.05B$3.98B35.3120,945News Coverage
Analyst Revision
MMSI
Merit Medical Systems
4.6223 of 5 stars
$91.12
-2.6%
$109.11
+19.7%
-2.9%$5.39B$1.36B44.677,400Positive News
Analyst Forecast
HAE
Haemonetics
4.8876 of 5 stars
$75.00
-2.4%
$96.80
+29.1%
-18.3%$3.60B$1.36B22.663,023News Coverage
ICUI
ICU Medical
4.3584 of 5 stars
$129.71
-4.2%
$192.67
+48.5%
+0.1%$3.19B$2.38B-33.8715,000News Coverage
Positive News
XRAY
DENTSPLY SIRONA
4.5871 of 5 stars
$15.94
-4.4%
$20.36
+27.8%
-40.5%$3.18B$3.79B-3.5114,000News Coverage
Analyst Revision
QDEL
QuidelOrtho
4.5183 of 5 stars
$29.22
-3.2%
$44.33
+51.7%
-26.6%$1.98B$2.78B-5.886,600News Coverage
NEOG
Neogen
4.035 of 5 stars
$4.98
-6.6%
$7.50
+50.6%
-71.0%$1.08B$906.00M-2.232,110Trending News
STAA
STAAR Surgical
3.1952 of 5 stars
$16.61
-7.0%
$24.63
+48.3%
-59.2%$822.63M$279.13M-11.531,211Analyst Forecast
Gap Up
CERS
Cerus
1.887 of 5 stars
$1.45
-5.8%
$3.50
+141.4%
-38.2%$277.18M$180.27M-14.50290

Related Companies and Tools


This page (NASDAQ:COO) was last updated on 7/20/2025 by MarketBeat.com Staff
From Our Partners